Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

A Flow Cytometric Method to Quantify the Endosomal Escape of a Protein Toxin to the Cytosol of Target Cells.

Wensley HJ, Johnston DA, Smith WS, Holmes SE, Flavell SU, Flavell DJ.

Pharm Res. 2019 Dec 23;37(1):16. doi: 10.1007/s11095-019-2725-1.

2.

Impact of Periprocedural and Technical Factors and Patient Characteristics on Revascularization and Outcome in the DAWN Trial.

Tekle WG, Hassan AE, Jadhav AP, Haussen DC, Budzik RF, Bonafe A, Bhuva P, Yavagal DR, Hanel RA, Ribo M, Cognard C, Sila CA, Smith WS, Saver JL, Liebeskind DS, Shields R, Nogueira RG, Jovin TG; DAWN Trial Investigators.

Stroke. 2020 Jan;51(1):247-253. doi: 10.1161/STROKEAHA.119.026437. Epub 2019 Nov 20.

PMID:
31744425
3.

A Unique Signature of Cardiac-Induced Cranial Forces During Acute Large Vessel Stroke and Development of a Predictive Model.

Smith WS, Keenan KJ, Lovoi PA.

Neurocrit Care. 2019 Oct 7. doi: 10.1007/s12028-019-00845-x. [Epub ahead of print]

PMID:
31591693
4.

Benefit of Endovascular Thrombectomy by Mode of Onset: Secondary Analysis of the DAWN Trial.

Jadhav AP, Aghaebrahim A, Jankowitz BT, Haussen DC, Budzik RF, Bonafe A, Bhuva P, Yavagal DR, Hanel RA, Hassan AE, Ribo M, Cognard C, Sila CA, Zhang Y, Smith WS, Saver JL, Liebeskind DS, Nogueira RG, Jovin TG.

Stroke. 2019 Nov;50(11):3141-3146. doi: 10.1161/STROKEAHA.119.025795. Epub 2019 Oct 1.

PMID:
31570085
5.

Outcome in Direct Versus Transfer Patients in the DAWN Controlled Trial.

Aghaebrahim A, Jadhav AP, Hanel R, Sauvageau E, Granja MF, Zhang Y, Haussen DC, Budzik RF, Bonafe A, Bhuva P, Ribo M, Cognard C, Sila C, Yavagal D, Hassan AE, Smith WS, Saver J, Liebeskind DS, Nogueira RG, Jovin TG; DAWN Investigators.

Stroke. 2019 Aug;50(8):2163-2167. doi: 10.1161/STROKEAHA.119.025710. Epub 2019 Jul 15.

PMID:
31303153
6.

Endovascular Stroke Therapy.

Smith WS.

Neurotherapeutics. 2019 Apr;16(2):360-368. doi: 10.1007/s13311-019-00724-5. Review.

PMID:
30838523
7.

Validation and iteration of CT perfusion defined malignant profile thresholds for acute ischemic stroke.

Keenan KJ, Christensen S, Inoue M, Mlynash M, Albers GW, Smith WS.

Int J Stroke. 2020 Jan;15(1):55-60. doi: 10.1177/1747493019832987. Epub 2019 Feb 22.

PMID:
30794104
8.

Augmentation of Saporin-Based Immunotoxins for Human Leukaemia and Lymphoma Cells by Triterpenoid Saponins: The Modifying Effects of Small Molecule Pharmacological Agents.

Smith WS, Johnston DA, Holmes SE, Wensley HJ, Flavell SU, Flavell DJ.

Toxins (Basel). 2019 Feb 20;11(2). pii: E127. doi: 10.3390/toxins11020127.

9.

The Speech Arm Vision Eyes (SAVE) scale predicts large vessel occlusion stroke as well as more complicated scales.

Keenan KJ, Smith WS.

J Neurointerv Surg. 2019 Jul;11(7):659-663. doi: 10.1136/neurintsurg-2018-014482. Epub 2018 Dec 4.

PMID:
30514735
10.

Mechanical Thrombectomy in Patients With Milder Strokes and Large Vessel Occlusions.

Nagel S, Bouslama M, Krause LU, Küpper C, Messer M, Petersen M, Lowens S, Herzberg M, Ringleb PA, Möhlenbruch MA, Tiedt S, Lima FO, Haussen DC, Smith WS, Lev MH, Nogueira RG.

Stroke. 2018 Oct;49(10):2391-2397. doi: 10.1161/STROKEAHA.118.021106.

PMID:
30355086
11.

A multiple hypothesis approach to explain species richness patterns in neotropical stream-dweller fish communities.

Vieira TB, Pavanelli CS, Casatti L, Smith WS, Benedito E, Mazzoni R, Sánchez-Botero JI, Garcez DS, Lima SMQ, Pompeu PS, Agostinho CS, Montag LFA, Zuanon J, Aquino PPU, Cetra M, Tejerina-Garro FL, Duboc LF, Corrêa RC, Pérez-Mayorga MA, Brejão GL, Mateussi NTB, Castro MA, Leitão RP, Mendonça FP, Silva LRPD, Frederico R, De Marco P.

PLoS One. 2018 Sep 19;13(9):e0204114. doi: 10.1371/journal.pone.0204114. eCollection 2018.

12.

Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.

Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG; DAWN Trial Investigators.

N Engl J Med. 2018 Jan 4;378(1):11-21. doi: 10.1056/NEJMoa1706442. Epub 2017 Nov 11.

13.

Periprocedural heparin use in acute ischemic stroke endovascular therapy: the TREVO 2 trial.

Winningham MJ, Haussen DC, Nogueira RG, Liebeskind DS, Smith WS, Lutsep HL, Jovin TG, Xiang B, Nahab F.

J Neurointerv Surg. 2018 Jul;10(7):611-614. doi: 10.1136/neurintsurg-2017-013441. Epub 2017 Oct 31.

PMID:
29089415
14.

Endovascular Stroke Therapy.

Caganap SD, Smith WS.

Semin Thromb Hemost. 2017 Nov;43(8):893-901. doi: 10.1055/s-0037-1603984. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750424
15.

Membrane cholesterol is essential for triterpenoid saponin augmentation of a saporin-based immunotoxin directed against CD19 on human lymphoma cells.

Smith WS, Baker EJ, Holmes SE, Koster G, Hunt AN, Johnston DA, Flavell SU, Flavell DJ.

Biochim Biophys Acta Biomembr. 2017 May;1859(5):993-1007. doi: 10.1016/j.bbamem.2017.02.013. Epub 2017 Feb 21.

16.

Field Assessment Stroke Triage for Emergency Destination: A Simple and Accurate Prehospital Scale to Detect Large Vessel Occlusion Strokes.

Lima FO, Silva GS, Furie KL, Frankel MR, Lev MH, Camargo ÉC, Haussen DC, Singhal AB, Koroshetz WJ, Smith WS, Nogueira RG.

Stroke. 2016 Aug;47(8):1997-2002. doi: 10.1161/STROKEAHA.116.013301. Epub 2016 Jun 30.

17.

A low-cost, tablet-based option for prehospital neurologic assessment: The iTREAT Study.

Chapman Smith SN, Govindarajan P, Padrick MM, Lippman JM, McMurry TL, Resler BL, Keenan K, Gunnell BS, Mehndiratta P, Chee CY, Cahill EA, Dietiker C, Cattell-Gordon DC, Smith WS, Perina DG, Solenski NJ, Worrall BB, Southerland AM; As the iTREAT Investigators.

Neurology. 2016 Jul 5;87(1):19-26. doi: 10.1212/WNL.0000000000002799. Epub 2016 Jun 8.

18.

Quantifiable Imaging Biomarkers for Evaluation of the Posterior Cruciate Ligament Using 3-T Magnetic Resonance Imaging: A Feasibility Study.

Wilson KJ, Surowiec RK, Ho CP, Devitt BM, Fripp J, Smith WS, Spiegl UJ, Dornan GJ, LaPrade RF.

Orthop J Sports Med. 2016 Apr 8;4(4):2325967116639044. doi: 10.1177/2325967116639044. eCollection 2016 Apr.

19.

Emergency Neurologic Life Support (ENLS): Evolution of Management in the First Hour of a Neurological Emergency.

Miller CM, Pineda J, Corry M, Brophy G, Smith WS.

Neurocrit Care. 2015 Dec;23 Suppl 2:S1-4. doi: 10.1007/s12028-015-0170-5. Review.

PMID:
26438452
20.

Brief History of Endovascular Acute Ischemic Stroke Treatment.

Smith WS, Furlan AJ.

Stroke. 2016 Feb;47(2):e23-6. doi: 10.1161/STROKEAHA.115.010863. Epub 2015 Oct 1. No abstract available.

PMID:
26429995
21.

Fluorocarbon nanodrops as acoustic temperature probes.

Mountford PA, Smith WS, Borden MA.

Langmuir. 2015 Oct 6;31(39):10656-63. doi: 10.1021/acs.langmuir.5b02308. Epub 2015 Sep 30.

PMID:
26359919
22.

REVASCAT Trial: Further Advancement in Endovascular Stroke Therapy.

Smith WS, Yan B.

Stroke. 2015 Oct;46(10):3012-3. doi: 10.1161/STROKEAHA.115.010817. Epub 2015 Sep 3. No abstract available.

PMID:
26337972
23.

Subregional Anatomical Distribution of T2 Values of Articular Cartilage in Asymptomatic Hips.

Ho CP, Surowiec RK, Ferro FP, Lucas EP, Saroki AJ, Dornan GJ, Fitzcharles EK, Anz AW, Smith WS, Wilson KJ, Philippon MJ.

Cartilage. 2014 Jul;5(3):154-64. doi: 10.1177/1947603514529587.

24.

Improved ischemic stroke outcome prediction using model estimation of outcome probability: the THRIVE-c calculation.

Flint AC, Rao VA, Chan SL, Cullen SP, Faigeles BS, Smith WS, Bath PM, Wahlgren N, Ahmed N, Donnan GA, Johnston SC; SITS International and VISTA-plus investigators.

Int J Stroke. 2015 Aug;10(6):815-21. doi: 10.1111/ijs.12529. Epub 2015 Jun 4.

PMID:
26045081
25.

Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.

Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A, Gupta R, Kirshner H, Megerian JT, Lesko J, Pitzer P, Ramos J, Castonguay AC, Barnwell S, Smith WS, Gress DR; VISSIT Trial Investigators.

JAMA. 2015 Mar 24-31;313(12):1240-8. doi: 10.1001/jama.2015.1693.

PMID:
25803346
26.

Cranial Accelerometry Can Detect Cerebral Vasospasm Caused by Subarachnoid Hemorrhage.

Smith WS, Browne JL, Ko NU.

Neurocrit Care. 2015 Dec;23(3):364-9. doi: 10.1007/s12028-015-0118-9.

PMID:
25761424
27.

Quantitative MRI characterization of arthroscopically verified supraspinatus pathology: comparison of tendon tears, tendinosis and asymptomatic supraspinatus tendons with T2 mapping.

Ganal E, Ho CP, Wilson KJ, Surowiec RK, Smith WS, Dornan GJ, Millett PJ.

Knee Surg Sports Traumatol Arthrosc. 2016 Jul;24(7):2216-24. doi: 10.1007/s00167-015-3547-2. Epub 2015 Mar 5.

PMID:
25739912
28.

A quality assurance initiative targeting radiation exposure to neuroscience patients in the intensive care unit.

Chan S, Josephson SA, Rosow L, Smith WS.

Neurohospitalist. 2015 Jan;5(1):9-14. doi: 10.1177/1941874414542440.

29.

The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.

Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA; SITS International and VISTA-plus investigators.

Int J Stroke. 2014 Aug;9(6):705-10. doi: 10.1111/ijs.12335. Epub 2014 Jul 15.

PMID:
25042855
30.

Contrast constancy revisited: the perceived contrast of sinusoidal gratings above threshold.

Smith WS.

Q J Exp Psychol (Hove). 2015;68(2):363-80. doi: 10.1080/17470218.2014.944919. Epub 2014 Sep 15.

PMID:
25026464
31.

Detection of concussion using cranial accelerometry.

Auerbach PS, Baine JG, Schott ML, Greenhaw A, Acharya MG, Smith WS.

Clin J Sport Med. 2015 Mar;25(2):126-32. doi: 10.1097/JSM.0000000000000117.

PMID:
25010149
32.

Predictors of functional dependence despite successful revascularization in large-vessel occlusion strokes.

Shi ZS, Liebeskind DS, Xiang B, Ge SG, Feng L, Albers GW, Budzik R, Devlin T, Gupta R, Jansen O, Jovin TG, Killer-Oberpfalzer M, Lutsep HL, Macho J, Nogueira RG, Rymer M, Smith WS, Wahlgren N, Duckwiler GR; Multi MERCI, TREVO, and TREVO 2 Investigators.

Stroke. 2014 Jul;45(7):1977-84. doi: 10.1161/STROKEAHA.114.005603. Epub 2014 May 29.

33.

Carotid I's, L's and T's: collaterals shape the outcome of intracranial carotid occlusion in acute ischemic stroke.

Liebeskind DS, Flint AC, Budzik RF, Xiang B, Smith WS, Duckwiler GR, Nogueira RG; MERCI and Multi-MERCI Investigators.

J Neurointerv Surg. 2015 Jun;7(6):402-7. doi: 10.1136/neurintsurg-2014-011231. Epub 2014 May 1.

34.

Symptom differences and pretreatment asymptomatic interval affect outcomes of stenting for intracranial atherosclerotic disease.

Alexander MD, Meyers PM, English JD, Stradford TR, Sung S, Smith WS, Halbach VV, Higashida RT, Dowd CF, Cooke DL, Hetts SW.

AJNR Am J Neuroradiol. 2014 Jun;35(6):1157-62. doi: 10.3174/ajnr.A3836. Epub 2014 Mar 27.

35.

Prognosis of untreated strokes due to anterior circulation proximal intracranial arterial occlusions detected by use of computed tomography angiography.

Lima FO, Furie KL, Silva GS, Lev MH, Camargo EC, Singhal AB, Harris GJ, Halpern EF, Koroshetz WJ, Smith WS, Nogueira RG.

JAMA Neurol. 2014 Feb;71(2):151-7. doi: 10.1001/jamaneurol.2013.5007.

PMID:
24323077
36.

Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices.

Saver JL, Jovin TG, Smith WS, Albers GW, Baron JC, Boltze J, Broderick JP, Davis LA, Demchuk AM, DeSena S, Fiehler J, Gorelick PB, Hacke W, Holt B, Jahan R, Jing H, Khatri P, Kidwell CS, Lees KR, Lev MH, Liebeskind DS, Luby M, Lyden P, Megerian JT, Mocco J, Muir KW, Rowley HA, Ruedy RM, Savitz SI, Sipelis VJ, Shimp SK 3rd, Wechsler LR, Wintermark M, Wu O, Yavagal DR, Yoo AJ; STAIR VIII Consortium.

Stroke. 2013 Dec;44(12):3596-601. doi: 10.1161/STROKEAHA.113.002769. Epub 2013 Nov 5.

37.

THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.

Flint AC, Faigeles BS, Cullen SP, Kamel H, Rao VA, Gupta R, Smith WS, Bath PM, Donnan GA; VISTA Collaboration.

Stroke. 2013 Dec;44(12):3365-9. doi: 10.1161/STROKEAHA.113.002794. Epub 2013 Sep 26.

PMID:
24072004
38.

THRIVE score predicts outcomes with a third-generation endovascular stroke treatment device in the TREVO-2 trial.

Flint AC, Xiang B, Gupta R, Nogueira RG, Lutsep HL, Jovin TG, Albers GW, Liebeskind DS, Sanossian N, Smith WS; TREVO-2 Trialists.

Stroke. 2013 Dec;44(12):3370-5. doi: 10.1161/STROKEAHA.113.002796. Epub 2013 Sep 26.

39.

Good outcome rate of 35% in IV-tPA-treated patients with computed tomography angiography confirmed severe anterior circulation occlusive stroke.

González RG, Furie KL, Goldmacher GV, Smith WS, Kamalian S, Payabvash S, Harris GJ, Halpern EF, Koroshetz WJ, Camargo EC, Dillon WP, Lev MH.

Stroke. 2013 Nov;44(11):3109-13. doi: 10.1161/STROKEAHA.113.001938. Epub 2013 Sep 3.

40.

Setting priorities for stroke care and research.

Morgenstern LB, Smith WS.

Int J Stroke. 2013 Aug;8(6):445-6. doi: 10.1111/ijs.12153.

41.

Time from onset of SIRS to antibiotic administration and outcomes after subarachnoid hemorrhage.

Guterman EL, Kamel H, Azran C, Shah MP, Claude Hemphill J 3rd, Smith WS, Navi BB.

Neurocrit Care. 2014 Aug;21(1):85-90. doi: 10.1007/s12028-013-9846-x.

PMID:
23839708
42.

Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis.

Zaidat OO, Castonguay AC, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A, Gupta R, Kirshner H, Eliasziw M, Thomas Megerian J, Shetty S, Yoklavich Guilhermier M, Barnwell S, Smith WS, Gress DR; VISSIT Trial Investigators.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1131-9. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.021. Epub 2012 Dec 21.

PMID:
23261207
43.

Pilot randomized trial of outpatient cardiac monitoring after cryptogenic stroke.

Kamel H, Navi BB, Elijovich L, Josephson SA, Yee AH, Fung G, Johnston SC, Smith WS.

Stroke. 2013 Feb;44(2):528-30. doi: 10.1161/STROKEAHA.112.679100. Epub 2012 Nov 27.

PMID:
23192756
44.

The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.

Kamel H, Patel N, Rao VA, Cullen SP, Faigeles BS, Smith WS, Flint AC.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1111-6. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.017. Epub 2012 Nov 2.

PMID:
23122722
45.

Density of thrombus on admission CT predicts revascularization efficacy in large vessel occlusion acute ischemic stroke.

Moftakhar P, English JD, Cooke DL, Kim WT, Stout C, Smith WS, Dowd CF, Higashida RT, Halbach VV, Hetts SW.

Stroke. 2013 Jan;44(1):243-5. doi: 10.1161/STROKEAHA.112.674127. Epub 2012 Oct 30.

PMID:
23111438
46.

Nonblurred regions show priority for gaze direction over spatial blur.

Smith WS, Tadmor Y.

Q J Exp Psychol (Hove). 2013;66(5):927-45. doi: 10.1080/17470218.2012.722659. Epub 2012 Oct 4.

PMID:
23035748
47.

Emergency neurological life support: traumatic brain injury.

Swadron SP, LeRoux P, Smith WS, Weingart SD.

Neurocrit Care. 2012 Sep;17 Suppl 1:S112-21. Review.

PMID:
22975830
48.

Emergency neurological life support: airway, ventilation, and sedation.

Seder DB, Riker RR, Jagoda A, Smith WS, Weingart SD.

Neurocrit Care. 2012 Sep;17 Suppl 1:S4-20. Review.

PMID:
22972019
49.

Emergency neurological life support: acute non-traumatic weakness.

Flower O, Bowles C, Wijdicks E, Weingart SD, Smith WS.

Neurocrit Care. 2012 Sep;17 Suppl 1:S79-95. Review.

PMID:
22972018
50.

Emergency neurological life support: traumatic spine injury.

Stein DM, Roddy V, Marx J, Smith WS, Weingart SD.

Neurocrit Care. 2012 Sep;17 Suppl 1:S102-11. Review.

PMID:
22965323

Supplemental Content

Loading ...
Support Center